Home/Filings/4/0001749705-19-000009
4//SEC Filing

WOJCZYNSKI DAVID E 4

Accession 0001749705-19-000009

CIK 0001552033other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 4:42 PM ET

Size

8.9 KB

Accession

0001749705-19-000009

Insider Transaction Report

Form 4
Period: 2019-06-14
WOJCZYNSKI DAVID E
EVP, Healthcare
Transactions
  • Exercise/Conversion

    Common Stock

    2019-06-14$8.57/sh+10,011$85,79444,395 total
  • Sale

    Common Stock

    2019-06-14$71.06/sh10,011$711,38234,384 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2019-06-17$8.57/sh10,011$85,7941,800 total
    Exercise: $8.57Exp: 2024-04-01Common Stock (10,011 underlying)
Footnotes (2)
  • [F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.04 to $71.10, inclusive. The reporting person undertakes to provide to TransUnion, any security holder of TransUnion, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]Represents an initial grant of 35,990 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017, and all options now follow the time-based vesting criteria as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter.

Issuer

TransUnion

CIK 0001552033

Entity typeother

Related Parties

1
  • filerCIK 0001749705

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:42 PM ET
Size
8.9 KB